Shares in ARS Pharmaceuticals were in freefall in pre ... aiming to become the first needle-free epinephrine product to treat severe allergic reactions. The nasal spray, dubbed neffy, has been ...
If pure math can teach us anything, it’s this: occasionally, your special interest might just change the world. For Joshua ...
neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...